Clinical Trials

Gold Divider 4Col

View All Service Areas

Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.

Institutes, Centers, Programs and Laboratories

The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.

More

Introduction to Clinical Trials

Introduction to Clinical Trials

Review frequently asked questions and introductory information about clinical trials.

More
List of Clinical Trials

Open Clinical Trial

Immunomodulatory Gene Therapy in Patients with Metastatic Breast Cancer: Phase I Trial of Adenoviral vector Delivery of the Human Interleukin-12 cDNA by Intratumoral Injection in Patients with Metastatic Breast Cancer

This is a research study of gene therapy to treat metastatic breast cancer. One of several tumors close to the skin (under the skin, in the chest wall, lymph nodes involved with cancer, or the breast cancer itself) are injected with a genetically altered virus. This altered virus (related to the "common cold" virus) cannot reproduce itself but can produce a substance called interleukin-12 (IL12). IL12 can enhance the ability of the body's immune system to destroy tumor cells. Blood tests and radiology scans will be performed before and after the virus injection to check for side effects and for decrease in the size of the tumors in the body. The virus injection has not been approved by the United States Food and Drug Administration (FDA) for commercial use in the treatment of metastatic breast cancer. Animal studies have shown that a single injection of the altered virus into tumors can destroy tumors in other organs as well and led to some of the treated animals living longer.

  • Phase

    I

  • Compensation

    N

  • Inclusion

    Women with metastatic breast cancer: - At least one metastatic tumor in the skin, chest wall, lymph nodes - Patients may have had prior treatment for breast cancer

  • Exclusion

    - Active infection, including HIV - Need to continue treatment with blood thinners (anticoagulants) such as warfarin or heparin

  • Research Study Site

    Mount Sinai Medical Center

  • Department Name

    MSSM Medicine

  • Contact Information

    Deborah Lehrer [Coordinator]
    R.N.
    deborah.lehrer@mssm.edu
    212-824-7308 8-7308

  • GCO Number

    02-0797

  • IRB Start/End Date

    June 20, 2009 to June 19, 2010

Coming to Mount Sinai?

Directions

Arrive at the Medical Center by car, public transportation and from all area airports.

More

Find A Faculty Member

Advanced Search

Events

Search for Events

Mount Sinai has scheduled events for faculty, physicians, students, staff, and the community. View events by day, week, and month.

View Events
(800) MD-SINAI (800) 637-4624
Print Page E-mail Page

Visit Mount Sinai Queens

Privacy Policy  |  Legal Statement     ©2009 Mount Sinai Medical Center